# Oxford University Innovation

> Oxford University Innovation is a VC fund backing Software and Biotechnology. See 68 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Oxford, United Kingdom
- Total investments: 68
- Last investment: Jul 2026
- Lead investor: 16%
- Last fund: Jan 2018
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/oxford-university-innovation/
- X (Twitter): https://twitter.com/OxUInnovation
- Website: https://innovation.ox.ac.uk/
- Facebook: https://www.facebook.com/Oxford-University-Innovation-450960058643334/

Oxford University Innovation is a VC fund in Oxford focused on Software and Biotechnology. Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation alsomanages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics.Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.”Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

## Contacts

5 contacts available for Oxford University Innovation. Shizune tracks 6 team members at Oxford University Innovation. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/oxford-university-innovation?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 21 | 31% |
| Biotechnology | 16 | 24% |
| Health Care | 13 | 19% |
| Artificial Intelligence | 9 | 13% |
| Medical | 8 | 12% |

105 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 25 | 37% |
| Seed | 21 | 31% |
| Series A | 9 | 13% |
| Pre-Seed | 3 | 4% |
| Series B | 3 | 4% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 55 | 81% |
| United States | 3 | 4% |
| Canada | 1 | 1% |
| Switzerland | 1 | 1% |
| The Netherlands | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Adam Stoten | Chief Operating Officer | 0 | https://shizune.co/investors/profile/adam-stoten |
| Gregg Bayes-Brown | Marketing and Communications Manager | 0 | https://shizune.co/investors/profile/gregg-bayes-brown |
| Mairi Gibbs | Head of Operations | 0 | https://shizune.co/investors/profile/mairi-gibbs |
| Ajoy Mallik | Oxford Angels Network | 0 | https://shizune.co/investors/profile/ajoy-mallik |
| Essa Saulat | Startup Mentor | 0 | https://shizune.co/investors/profile/essa-saulat |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MoA Technology | MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems. | $29.7M | Series C | Jul 23, 2026 |  |
| Endlyz Therapeutics | ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias. | $17.3M | Seed | Apr 23, 2026 |  |
| Scripta Therapeutics | Scripta Therapeutics operates as a bio-tech company, that delivers transformative therapeutics through cutting edge technology. | $12M | Seed | Nov 13, 2025 |  |
| DaltonTx | DaltonTx platform provides pharma, biotech, and CROs with the intelligence backbone that modern R&D and redefining how technology powers drug discovery. | $5.4M | Seed | Sep 23, 2025 |  |
| Palmer Energy Technology | Palmer Energy Technology offers advanced battery energy storage system technologies to secure customized, scalable, clean energy systems that reduce carbon emissions and enhance energy independence. | $6.8M | Series A | Aug 28, 2025 |  |
| Oria XR | Oria XR is an innovative startup dedicated to revolutionizing medical training through the power of Virtual Reality (VR) and extended reality (XR) technologies. Our mission is to empower medical professionals and engineers with cutting-edge technology and unparalleled training experiences, ensuring they have the skills and confidence needed toexcel in their fields. At Oria XR, we believe in setting the gold standard in medical training and support. | $12.9K | Pre-Seed | Jul 26, 2024 |  |
| CryoLogyx | CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery. Their exclusive technology is transforming cell freezing, storage, and transportation. Innovation ensures the delivery of viable cells and cell therapies in the appropriate format, ready to use whenever our customers require them. | $636.3K | Seed | Mar 18, 2024 |  |
| Caristo Diagnostics | Caristo Diagnostics is revolutionizing cardiovascular diagnostics and risk prediction with its advanced, AI-based CT imaging analysis tools. | $16.3M | Series A | Apr 17, 2023 |  |
| Brill Power | Brill Power is a clean-tech platform that develops cutting-edge battery management technology to increase the lifetime performance of lithium-ion battery packs. Founded in 2016, the company is headquartered in Oxford, England. | $10.5M | Series A | Jul 19, 2022 |  |
| Brainomix | Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time. | $21.3M | Series B | Dec 16, 2021 |  |

10 of 68 investments shown.

## Co-investors
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 19 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 11 deals together
- [Parkwalk Advisors](https://shizune.co/investors/profile/parkwalk-advisors) — VC Fund, 8 deals together
- [Oxford Investment Consultants LLP](https://shizune.co/investors/profile/oxford-technology-and-innovations-fund) — VC Fund, 6 deals together
- [IP Group](https://shizune.co/investors/profile/ip-group-plc) — VC Fund, 5 deals together
- [Oxford Technology Management](https://shizune.co/investors/profile/oxford-technology-management) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Oxford University Innovation invest in?

Oxford University Innovation invests primarily in Software, Biotechnology and Health Care startups, most often at Funding Round and Seed stage. Most of the 68 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Oxford University Innovation?

Public channels for Oxford University Innovation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Oxford University Innovation?

The team at Oxford University Innovation includes Adam Stoten (Chief Operating Officer), Gregg Bayes-Brown (Marketing and Communications Manager) and Mairi Gibbs (Head of Operations), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co